Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baroni

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Archiv Der Pharmazie|December 19, 2022
Repurposing of 5-nitrofuran-3,5-disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agentsDiego B Carvalho, Amarith R das Neves, Gisele B Portapilla, et al.
ACS Infectious Diseases|April 27, 2023
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical StudyAmarith R das Neves, Diego B Carvalho, Fernanda Silva, et al.
Archiv Der Pharmazie|December 17, 2019
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffoldsOzildéia S Trefzger, Natália V Barbosa, Renata L Scapolatempo, et al.
Pharmaceutics|January 28, 2026
New Copper (II) Complexes Based on 1,4-Disubstituted-1,2,3-Triazole Ligands with Promising Antileishmanial ActivityJoão P C Nascimento, Natali L Faganello, Karolina F Freitas, et al.
European Journal of Medicinal Chemistry|August 12, 2023
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazoleDiego B Carvalho, Pedro A N Costa, Gisele B Portapilla, et al.
Hipertension Y Riesgo Vascular|July 26, 2025
Statins and preeclampsia: An update from the Working Group on Hypertension in Women, Argentine Society of HypertensionA M Ghelfi, G Miranda, L S Voto, et al.
Chemmedchem|November 20, 2024
Design and Synthesis of 2-Nitroimidazole-1,2,3-triazole Sulfonamide Hybrids as Potent and Selective Anti-Trypanosomatid AgentsVictória C Tietz, Maria L F Ortale, Amarith R das Neves, et al.
European Journal of Medicinal Chemistry|March 20, 2025
Exploring chloro-isoxazole compounds inspired on tetrahydrofuran neolignans as promising antileishmanial agentsAmarith R das Neves, Diego B Carvalho, Luiz F P Pereira, et al.
ACS Chemical Neuroscience|December 4, 2023
Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive ImpairmentVictor H B de Andrade, Erick Y M Rodrigues, Nayara A F Dias, et al.
Journal of Medicinal Chemistry|February 2, 2024
Design and Synthesis of Novel 3-Nitro-1<i>H</i>-1,2,4-triazole-1,2,3-triazole-1,4-disubstituted Analogs as Promising Antitrypanosomatid Agents: Evaluation of In Vitro Activity against Chagas Disease and LeishmaniasisBruno I Pelizaro, Jaqueline C Z Batista, Gisele B Portapilla, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Archiv Der Pharmazie|December 19, 2022
Repurposing of 5-nitrofuran-3,5-disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agentsDiego B Carvalho, Amarith R das Neves, Gisele B Portapilla, et al.
ACS Infectious Diseases|April 27, 2023
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical StudyAmarith R das Neves, Diego B Carvalho, Fernanda Silva, et al.
Archiv Der Pharmazie|December 17, 2019
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffoldsOzildéia S Trefzger, Natália V Barbosa, Renata L Scapolatempo, et al.
Pharmaceutics|January 28, 2026
New Copper (II) Complexes Based on 1,4-Disubstituted-1,2,3-Triazole Ligands with Promising Antileishmanial ActivityJoão P C Nascimento, Natali L Faganello, Karolina F Freitas, et al.
European Journal of Medicinal Chemistry|August 12, 2023
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazoleDiego B Carvalho, Pedro A N Costa, Gisele B Portapilla, et al.
Hipertension Y Riesgo Vascular|July 26, 2025
Statins and preeclampsia: An update from the Working Group on Hypertension in Women, Argentine Society of HypertensionA M Ghelfi, G Miranda, L S Voto, et al.
Chemmedchem|November 20, 2024
Design and Synthesis of 2-Nitroimidazole-1,2,3-triazole Sulfonamide Hybrids as Potent and Selective Anti-Trypanosomatid AgentsVictória C Tietz, Maria L F Ortale, Amarith R das Neves, et al.
European Journal of Medicinal Chemistry|March 20, 2025
Exploring chloro-isoxazole compounds inspired on tetrahydrofuran neolignans as promising antileishmanial agentsAmarith R das Neves, Diego B Carvalho, Luiz F P Pereira, et al.
ACS Chemical Neuroscience|December 4, 2023
Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive ImpairmentVictor H B de Andrade, Erick Y M Rodrigues, Nayara A F Dias, et al.
Journal of Medicinal Chemistry|February 2, 2024
Design and Synthesis of Novel 3-Nitro-1<i>H</i>-1,2,4-triazole-1,2,3-triazole-1,4-disubstituted Analogs as Promising Antitrypanosomatid Agents: Evaluation of In Vitro Activity against Chagas Disease and LeishmaniasisBruno I Pelizaro, Jaqueline C Z Batista, Gisele B Portapilla, et al.
Pageof 19